Literature DB >> 20855753

Prediction of the adequacy of lymph node retrieval in colon cancer by hospital type.

Maheswari Senthil1, Vijay Trisal, I Benjamin Paz, Lily L Lai.   

Abstract

BACKGROUND: Examination of 12 or more regional lymph nodes (LNs) is the accepted minimum for nodal staging in colon cancer and serves as a surrogate for adequate resection.
OBJECTIVE: To determine the contributing role of the hospital in the number of LNs retrieved. Design/
SETTING: We retrospectively reviewed colon resections in 83 patients by 2 surgical oncologists at a National Comprehensive Cancer Network (NCCN) hospital or at community-based hospitals from January 1, 2002, through December 31, 2007. PATIENTS: We included all patients undergoing colectomy for primary colon cancer and excluded patients with recurrence, rectal cancer, or preoperative chemotherapy. MAIN OUTCOME MEASURES: Total number of LNs retrieved. We also analyzed clinical factors accounting for differences.
RESULTS: The median number of LNs examined at the NCCN hospital (42 patients) vs the community hospitals (41 patients) were 17.8 vs 7.0 (P < .001), and the frequency of an inadequate number of LNs examined (<12) was 11 of 42 cases (26%) vs 35 of 41 cases (85%) (P < .001). Potential predictive factors for LNs retrieved were grouped into modifiable (hospital type, surgeon, and surgical approach [laparoscopic vs open]) and nonmodifiable (age, sex, and tumor location). On multivariate analysis of the factors, hospital type was the only modifiable factor predictive of LNs reported (P < .001).
CONCLUSIONS: Our study is the first, to our knowledge, to demonstrate that the number of LNs removed in colectomies performed by the same 2 surgeons depends on the hospital type (NCCN vs community) in which the resection occurred. We postulate that the number of LNs retrieved may be related to the institution's pathological review in addition to the extent of surgical resection.

Entities:  

Mesh:

Year:  2010        PMID: 20855753     DOI: 10.1001/archsurg.2010.182

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  9 in total

1.  Extended lymphadenectomy in colon cancer is debatable.

Authors:  Jamie Murphy; Tonia Young-Fadok
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

2.  Predictors of lymph node count in colorectal cancer resections: data from US nationwide prospective cohort studies.

Authors:  Teppei Morikawa; Noriko Tanaka; Aya Kuchiba; Katsuhiko Nosho; Mai Yamauchi; Jason L Hornick; Richard S Swanson; Andrew T Chan; Jeffrey A Meyerhardt; Curtis Huttenhower; Deborah Schrag; Charles S Fuchs; Shuji Ogino
Journal:  Arch Surg       Date:  2012-08

Review 3.  Colorectal cancer and lymph nodes: the obsession with the number 12.

Authors:  Giovanni Li Destri; Isidoro Di Carlo; Roberto Scilletta; Beniamino Scilletta; Stefano Puleo
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

4.  Time trends and disparities in lymphadenectomy for gastrointestinal cancer in the United States: a population-based analysis of 326,243 patients.

Authors:  A Dubecz; N Solymosi; M Schweigert; R J Stadlhuber; J H Peters; D Ofner; H J Stein
Journal:  J Gastrointest Surg       Date:  2013-01-24       Impact factor: 3.452

Review 5.  Stage migration vs immunology: The lymph node count story in colon cancer.

Authors:  Bruno Märkl
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

6.  Improving quality of cancer care at community hospitals: impact of the National Cancer Institute Community Cancer Centers Program pilot.

Authors:  Michael T Halpern; Pamela Spain; Debra J Holden; Andrew Stewart; Erica J McNamara; Greer Gay; Irene Prabhu Das; Steven Clauser
Journal:  J Oncol Pract       Date:  2013-08-13       Impact factor: 3.840

7.  Spatially varying effects of predictors for the survival prediction of nonmetastatic colorectal Cancer.

Authors:  Yu Tian; Jun Li; Tianshu Zhou; Danyang Tong; Shengqiang Chi; Xiangxing Kong; Kefeng Ding; Jingsong Li
Journal:  BMC Cancer       Date:  2018-11-08       Impact factor: 4.430

8.  Adoption of single agent anticancer therapy for advanced hepatocellular carcinoma and impact of facility type, insurance status, and income on survival: Analysis of the national cancer database 2004-2014.

Authors:  Aman Opneja; Gino Cioffi; Asrar Alahmadi; Nelroy Jones; Tin-Yun Tang; Nirav Patil; David L Bajor; Joel N Saltzman; Amr Mohamed; Eva Selfridge; Ankit Mangla; Jill Barnholtz-Sloan; Richard T Lee
Journal:  Cancer Med       Date:  2021-05-31       Impact factor: 4.711

9.  Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach?

Authors:  Cary Jo R Schlick; Rhami Khorfan; David D Odell; Ryan P Merkow; David J Bentrem
Journal:  Ann Surg Oncol       Date:  2020-06-09       Impact factor: 4.339

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.